Eric Shaff
Chief Executive Officer bij SERES THERAPEUTICS, INC.
Vermogen: 104 738 $ op 31-07-2023
Profiel
Eric D.
Shaff is currently the President, Chief Executive Officer & Director at Seres Therapeutics, Inc. He previously served as an Independent Director at Sigilon Therapeutics, Inc. from 2017 to 2023.
Eric also worked as a Principal at Pfizer Inc. and as the Global Head-Rare Genetic Disease Finance at Genzyme Corp.
from 2004 to 2011.
Additionally, he held the position of Vice President-Corporate Finance at Momenta Pharmaceuticals, Inc. from 2012 to 2014.
Eric started his career as a Senior Analyst at Broadview International LLC.
He completed his undergraduate studies at the University of Pennsylvania and earned an MBA from the Johnson Graduate School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SERES THERAPEUTICS INC
0.09% | 16-02-2024 | 135 321 ( 0.09% ) | 104 738 $ | 31-03-2024 |
| 11-08-2023 | 0 ( -.--% ) | - $ | 31-07-2023 |
Actieve functies van Eric Shaff
| Bedrijven | Functie | Begin |
|---|---|---|
| SERES THERAPEUTICS, INC. | Chief Executive Officer | 15-01-2019 |
Eerdere bekende functies van Eric Shaff
| Bedrijven | Functie | Einde |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Director/Board Member | 11-08-2023 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-11-2014 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-12-2011 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Broadview International LLC
 Broadview International LLC Investment Banks/BrokersFinance Jefferies Broadview, a division of Jefferies & Company, Inc. provides services to the information technology, communications, healthcare technology and digital media industries. The firm addresses six major technology segments: communications technology, semiconductors and electronics manufacturing, enterprise software, digital media, and information technology services. Jefferies Broadview consists of 90 investment bankers operating in the US, Europe and Asia. The company provides investment banking services including debt and equity underwriting, private placements, M&A and restructuring advisory services. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
Opleiding van Eric Shaff
| University of Pennsylvania | Undergraduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Broadview International LLC
Broadview International LLC Investment Banks/BrokersFinance Jefferies Broadview, a division of Jefferies & Company, Inc. provides services to the information technology, communications, healthcare technology and digital media industries. The firm addresses six major technology segments: communications technology, semiconductors and electronics manufacturing, enterprise software, digital media, and information technology services. Jefferies Broadview consists of 90 investment bankers operating in the US, Europe and Asia. The company provides investment banking services including debt and equity underwriting, private placements, M&A and restructuring advisory services. The company is headquartered in New York, NY. | Finance |
